DiscussierInsilico Medicine
Insilico Medicine is a clinical-stage AI-driven drug discovery company that uses generative AI and deep learning across every stage of the pharmaceutical pipeline, from target identification to clinical trial design. The company's Pharma.AI platform encompasses three core modules: PandaOmics for target discovery, Chemistry42 for molecule generation, and InClinico for clinical trial outcome prediction. Insilico has advanced multiple AI-discovered drug candidates into clinical trials, including...